Predicted Trait | |
Reported Trait | Peripheral artery disease |
Mapped Trait(s) | peripheral arterial disease (EFO_0004265) |
Score Construction | |
PGS Name | PRS19_PAD |
Development Method | |
Name | Genome-wide significant SNPs |
Parameters | NR |
Variants | |
Original Genome Build | NR |
Number of Variants | 19 |
Effect Weight Type | log(OR) |
PGS Source | |
PGS Catalog Publication (PGP) ID | PGP000705 |
Citation (link to publication) | Zhu K et al. Diabetes Care (2024) |
Ancestry Distribution | |
Source of Variant Associations (GWAS) | European: 72% African: 19.7% Hispanic or Latin American: 8.3% 243,060 individuals (100%) |
PGS Evaluation | European: 100% 1 Sample Sets |
Study Identifiers | Sample Numbers | Sample Ancestry | Cohort(s) |
---|---|---|---|
GWAS Catalog: GCST008474 Europe PMC: 31285632 |
174,992 individuals | European | NR |
GWAS Catalog: GCST008474 Europe PMC: 31285632 |
47,858 individuals | African unspecified | NR |
GWAS Catalog: GCST008474 Europe PMC: 31285632 |
20,210 individuals | Hispanic or Latin American | NR |
PGS Performance Metric ID (PPM) |
PGS Sample Set ID (PSS) |
Performance Source | Trait |
PGS Effect Sizes (per SD change) |
Classification Metrics | Other Metrics | Covariates Included in the Model |
PGS Performance: Other Relevant Information |
---|---|---|---|---|---|---|---|---|
PPM022379 | PSS011930| European Ancestry| 10,836 individuals |
PGP000705 | Zhu K et al. Diabetes Care (2024) |
Reported Trait: Peripheral artery disease in type 2 diabetes x lifestyle interaction | — | — | Hazard ratio (HR, unfavorable lifestyle and high PRS vs. favorable life style and low PRS): 5.03 [2.74, 9.22] | age (continuous, years), sex (male, female), education attainment (college or university degree, A/AS levels or equivalent or O levels/ GCSEs or equivalent or other professional qualifications, or none of the above), Townsend Deprivation Index (continuous), family history of CVD (yes, no), prevalence of hypertension (yes, no), use of antihypertensive medication (yes, no), use of lipid-lowing medication (yes, no), aspirin use (yes, no), diabetes duration (continuous, years), HbA1c (continuous, %), use of diabetes medication (none, only oral medication pills, only insulin, or combination of oral medications and insulin), genotype measurement batch, and the first 10 principal components of ancestry | fig 1 |
PPM022378 | PSS011930| European Ancestry| 10,836 individuals |
PGP000705 | Zhu K et al. Diabetes Care (2024) |
Reported Trait: Peripheral artery disease in type 2 diabetes | HR: 1.13 [1.03, 1.23] | — | — | age (continuous, years), sex (male, female), Townsend Deprivation Index (continuous), race/ethnicity (White, others), education attainment (college or university degree, A/AS levels or equivalent or O levels/GCSEs or equivalent or other professional qualifications, or none of the above), family history of CVD (yes, no), prevalence of hypertension (yes, no), use of antihypertensive medication (yes, no), use of lipidlowing medication (yes, no), use of aspirin (yes, no), diabetes duration (continuous, years), HbA1c (continuous, %), use of diabetes medication (none, only oral medication pills, or only insulin or combination of oral medications and insulin), genotype measurement batch, the first 10 principal components of ancestry, weighted healthy lifestyle scores (continuous) | ST3 |
PGS Sample Set ID (PSS) |
Phenotype Definitions and Methods | Participant Follow-up Time | Sample Numbers | Age of Study Participants | Sample Ancestry | Additional Ancestry Description | Cohort(s) | Additional Sample/Cohort Information |
---|---|---|---|---|---|---|---|---|
PSS011930 | — | — | 10,836 individuals | — | European (British) |
— | UKB | — |